Value Bridge — MEDICAL CITY DALLAS
Current $106M → Target $135M (+$29.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$106.0M
Current EBITDA
$135.3M
Target EBITDA
+$29.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$6.6M
Payer Mix Optimization
$15.9M
Cost to Collect Reduction
$5.3M
Clean Claim Improvement
$4.0M
Volume & Rate Growth
$26.5M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $106M to $135M. The highest-impact lever is Volume & Rate Growth at $10.6M probability-weighted.
IC talking point: "We see $29M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $322M in equity value creation."